Merck KGaA in no rush to join M&A bandwagon
This article was originally published in Scrip
Executive Summary
German pharma and chemicals firm Merck KGaA reported an uninspiring set of second quarter figures. Net profit slipped 4% to €303m but the company backed its full-year forecast.